CIBC Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-996
Closed -$324K 1223
2024
Q1
$324K Buy
+996
New +$245K ﹤0.01% 808
2023
Q3
Sell
-996
Closed -$284K 1115
2023
Q2
$284K Hold
996
﹤0.01% 830
2023
Q1
$216K Buy
+996
New +$194K ﹤0.01% 911
2022
Q4
Sell
-1,327
Closed -$369K 1286
2022
Q3
$369K Hold
1,327
﹤0.01% 824
2022
Q2
$254K Sell
1,327
-97
-7% -$17.1K ﹤0.01% 964
2022
Q1
$295K Hold
1,424
﹤0.01% 1076
2021
Q4
$254K Sell
1,424
-1
-0.1% -$197 ﹤0.01% 1195
2021
Q3
$293K Buy
1,425
+141
+11% +$27.7K ﹤0.01% 1036
2021
Q2
$244K Buy
+1,284
New +$210K ﹤0.01% 1128

Other funds holding SWAV

CIBC Asset Management's SWAV Position: Q2 2024 in Review

CIBC Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 996 shares — an estimated $324K sold.

CIBC Asset Management first reported a position in SWAV in Q2 2021 and held it in 9 quarters. The position peaked at $369K in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • CIBC Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • CIBC Asset Management sold 996 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $324K.
  • CIBC Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • CIBC Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $369K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.